EV/EBITDA
-5.05
-0.34-7.22%
28 min ago
Summary:
Lineage Cell Therapeutics EV/EBITDA is currently -5.05, with a fall of -0.34 (-7.22%) during the most recent trading day. Over the past year, it has increased by +0.98 (+16.25%). LCTX EV/EBITDA is now -2557.89% below its all-time high of -0.19.LCTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -7.2% |
| 1 m1 month | +19.8% |
| 3 m3 months | +14.4% |
| 6 m6 months | +11.6% |
| ytdytd | +23.3% |
| 1 y1 year | +16.3% |
| 5 y5 years | -57.3% |
LCTX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -4.24 | -19.1% | -7.16 | +29.5% |
| 3 m | 3 months | -4.24 | -19.1% | -7.16 | +29.5% |
| 6 m | 6 months | -4.24 | -19.1% | -7.16 | +29.5% |
| 1 y | 1 year | -4.24 | -19.1% | -10.33 | +51.1% |
| 3 y | 3 years | -2.40 | -110.4% | -15.24 | +66.9% |
| 5 y | 5 years | -1.83 | -176.0% | -18.27 | +72.4% |
| alltime | all time | -0.19 | -2557.9% | -675.37 | +99.3% |
Lineage Cell Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -5.05(-23.3%) |
| 2023 | -6.58(-25.1%) |
| 2022 | -8.79(+17.4%) |
| 2021 | -7.49(-24.0%) |
| 2020 | -9.86(+173.9%) |
| 2019 | -3.60(+44.6%) |
| 2018 | -2.49(-60.8%) |
| 2017 | -6.36(-2.3%) |
| 2016 | -6.51(+16.0%) |
| 2015 | -5.61(-9.7%) |
| 2014 | -6.21(+8.0%) |
| 2013 | -5.75(-15.4%) |
| 2012 | -6.80(-57.7%) |
| 2011 | -16.08(-57.8%) |
| 2010 | -38.06(-6.9%) |
| 2009 | -40.89(+200.9%) |
| Date | Value |
|---|---|
| 2008 | -13.59(+60.6%) |
| 2007 | -8.46(+151.8%) |
| 2006 | -3.36(+32.8%) |
| 2005 | -2.53(-90.9%) |
| 2004 | -27.74(+17.2%) |
| 2003 | -23.67(+57.6%) |
| 2002 | -15.02(-11.5%) |
| 2001 | -16.98(+0.7%) |
| 2000 | -16.87(+6.4%) |
| 1999 | -15.86(-64.3%) |
| 1998 | -44.42(-9.1%) |
| 1997 | -48.85(+84.0%) |
| 1996 | -26.55(+1170.3%) |
| 1994 | -2.09(-76.7%) |
| 1993 | -8.98(-28.6%) |
| 1992 | -12.58 |
FAQ
- What is Lineage Cell Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Lineage Cell Therapeutics?
- What is LCTX EV/EBITDA year-to-date change?
- What is Lineage Cell Therapeutics EV/EBITDA year-on-year change?
What is Lineage Cell Therapeutics EV/EBITDA?
The current EV/EBITDA of LCTX is -5.05
What is the all time high EV/EBITDA for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high EV/EBITDA is -0.19
What is LCTX EV/EBITDA year-to-date change?
Lineage Cell Therapeutics EV/EBITDA has changed by +1.53 (+23.25%) since the beginning of the year
What is Lineage Cell Therapeutics EV/EBITDA year-on-year change?
Over the past year, LCTX EV/EBITDA has changed by +0.98 (+16.25%)